The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia
- 1 October 2011
- journal article
- research article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 96 (10), 1560-1564
- https://doi.org/10.3324/haematol.2011.046417
Abstract
Th17 cells have been associated with immune-mediated diseases in humans but it has still not been determined whether they play a role in immune thrombocytopenia. We evaluated representative cytokines of the Th17, Th1, Th2 and Treg cell commitment in the serum of patients with chronic immune thrombocytopenia, as well as the cell source of IL-17A. Higher levels of IL-17A and Th17-related cytokines, and an increased percentage of IL-17A producing CD4+ and neutrophils were observed in patients. The levels of cytokines involved in Th1 cell commitment IFN-gamma,IL-2, IL12-p70 and the percentages of Th1 cells were also increased, but IL-4 was not detected. Although the concentrations of IL-10 were higher, the levels of TGF-beta were similar in both groups. In conclusion, our results point to a putative role for Th-17 cells/IL-17A cytokine in the pathogenesis of chronic immune thrombocytopenia.Keywords
This publication has 22 references indexed in Scilit:
- research paper: IL1RN VNTR and IL2−330 polymorphic genes are independently associated with chronic immune thrombocytopeniaBritish Journal of Haematology, 2010
- International consensus report on the investigation and management of primary immune thrombocytopeniaBlood, 2010
- Antiplatelet Antibodies in Chronic Immune Thrombocytopenia and Their Role in Platelet Destruction and Defective Platelet ProductionHematology/Oncology Clinics of North America, 2009
- Elevated Interleukin-21 Correlated to Th17 and Th1 Cells in Patients with Immune ThrombocytopeniaJournal of Clinical Immunology, 2009
- Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpuraHaematologica, 2009
- Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosusNature Immunology, 2009
- Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune responseBlood, 2004
- T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpuraNature Medicine, 2003
- Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanerceptAmerican Journal of Hematology, 2003
- Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivityBlood, 1996